The symptoms of anxiety and depression overlap in many ways—both conditions create irritability, insomnia, and difficulty concentrating, for example. Researchers know that some of the same brain ...
In such cases, doctors often explore additional strategies, such as switching to another antidepressant or combining ... could help prevent depression and anxiety. For more information about ...
Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...
Keep yourself safe from phishing attacks, hackers and malware with the best antivirus software. Here are CNET's top picks for web protection, malware detection and more. Dianna Gunn built her ...
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.
Vortioxetine (Lu AA21004) is under investigation as an antidepressant for the treatment of major depressive disorder (MDD) in adult patients. It is thought to work through a combination of two ...
Caroline Igo (she/her/hers) is a wellness editor and holds Sleep Science Coach and Stress Management certificates from the Spencer Institute. She received her bachelor's degree in creative writing ...
Following U.S. FDA Priority Review, approval is based on data demonstrating SPRAVATO® alone met its primary endpoint at 4 weeks and led to rapid and superior improvement in depressive symptoms ...